October 05, 2018
An Arizona federal jury on Friday cleared C.R. Bard Inc. of liability in the third bellwether trial over claims that the company's clot-stopping vein filter could break and send metal pieces toward patients' hearts.
October 02, 2018
An Arizona federal judge nixed certain damages claims Tuesday in an ongoing Bard bellwether trial over its clot-stopping vein filters, while the device maker told a jury that a certain amount of malfunctioning is to be expected from them.
July 26, 2018
An Arizona federal judge Thursday trimmed claims from a bellwether case in multidistrict litigation alleging that C.R. Bard Inc.'s blood vessel filters are dangerously defective, saying that the patient didn't show that an inadequate warning caused her injuries.
July 13, 2018
An Arizona federal judge on Thursday canceled the third bellwether trial of claims that C.R. Bard Inc. sold hazardously defective blood vessel filters and granted Bard summary judgment, saying the statute of limitations had expired on the claims.
June 20, 2018
Medical device maker C.R. Bard is stuck with a $3.6 million jury verdict awarded in a multidistrict litigation test trial over the safety of its clot-stopping vein filters, after an Arizona federal court denied Bard's requests for a new trial or judgment as a matter of law.
April 24, 2018
Medical device maker C.R. Bard on Monday moved for a new trial after being hit with a $3.6 million verdict last month in a multidistrict litigation test trial over the safety of its clot-stopping vein filters, telling an Arizona federal court the decision was "inconsistent" and rested on flimsy evidence.
March 30, 2018
A Phoenix federal jury awarded $2 million in compensatory damages and $2 million in punitive damages on Friday to a woman who said a clot-stopping vein filter manufactured by C.R. Bard Inc. broke apart in her body, finding the device maker responsible for 80 percent of the harm for a total of $3.6 million in damages.
March 29, 2018
A Phoenix federal jury began deliberations Thursday in the first bellwether trial in multidistrict litigation over claims that device maker Bard's clot-stopping vein implants splintered and migrated towards patients' hearts, after Bard closed its case by arguing evidence concerning predecessor implants and FDA warnings were red herrings.
November 27, 2017
An Arizona federal judge has shot down C.R. Bard Inc.'s request to escape multidistrict litigation brought by individuals who say they or their family members were injured or killed by the company's allegedly defective vascular filters, ruling that their state law claims aren't preempted by federal law.